Amplitude Surgical (XPAR:AMPLI) ROCE % : 4.43% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Amplitude Surgical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Amplitude Surgical's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.43%.

Amplitude Surgical ROCE % Historical Data

The historical data trend for Amplitude Surgical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplitude Surgical ROCE % Chart

Amplitude Surgical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

-0.36

-2.01

-0.79

3.42

2.30

Amplitude Surgical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															2.60	4.26	1.96	2.72	4.43

Amplitude Surgical ROCE % Calculation

Amplitude Surgical's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	5.054	/	( ( (259.462 - 43.834)	+	(266.016 - 41.325) )	/ 2 )
	=	5.054	/	( (215.628	+	224.691)	/ 2 )
	=	5.054	/	220.1595
	=	2.30 %

Amplitude Surgical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	9.982	/	( ( (266.016 - 41.325)	+	(268.58 - 42.667) )	/ 2 )
	=	9.982	/	( ( 224.691	+	225.913 )	/ 2 )
	=	9.982	/	225.302
	=	4.43 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Amplitude Surgical (XPAR:AMPLI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Amplitude Surgical ROCE % Related Terms

Thank you for viewing the detailed overview of Amplitude Surgical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplitude Surgical (XPAR:AMPLI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amplitude Surgical (XPAR:AMPLI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

1AU:Germany

Address

11 cours Jacques Offenbach, Valence, FRA, 26000

Website

https://www.amplitude-surgical.com

Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.

Amplitude Surgical (XPAR:AMPLI) Headlines

No Headlines